NL-OMON54420招募中2 期
Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection - a controlled human infection study - CHIMP
niversitair Medisch Centrum Utrecht0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1. Healthy males or females
- •2. Age 18-55 years
- •3. Signed and dated informed consent form
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study: 1. Child younger than 3 years old living in
- •subject*s household 2. Person older than 65 years old or significant primary or
- •secondary immunodeficiency living in subjects household 3. Presence of
- •significant acute or chronic medical illness that is associated with increased
- •risk of respiratory viral illness related complications. These include but are
- •not limited to: a. Recent (within adulthood) history of asthma, COPD,
- •hypertension, reactive airway disease, or any other chronic lung illness b.
- •History or evidence of impaired immune responsivity or autoimmune disease c.
- •Confirmed hepatitis B (HBV), human immunodeficiency virus (HIV), or hepatitis C
- •(HCV) test 4. Adults with a nasal cold or obstructions which could interfere
- •with administration of the study intervention 5. Simultaneous use of other
- •nasal drops, sprays, or medications 6. Nasal surgery prior to or during the
- •trial 7. Positive COVID-test 48 hours prior to start of the study 8. Pregnancy
- •9. Symptoms of clear nasal congestion
研究者
相似试验
撤回
2 期
Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection * a human challenge studybronchiolitisNL-OMON55009niversitair Medisch Centrum Utrecht34
进行中（未招募）
1 期
asal administration of palivizumab in an RSV human challenge modelrespiratory syncytial virus infectionEUCTR2020-004137-21-NLniversity Medical Center Utrecht34
进行中（未招募）
1 期
asal administration of palivizumab to prevent respiratory syncytial virus infectiorespiratory syncytial virus infectionEUCTR2018-002742-37-NLniversity Medical Center Utrecht408
Unknown
不适用
asal administration of palivizumab toprevent RSV infectioRespiratory Syncytial Virus (RSV), Palivizumab, respiratoir syncytieel virus (RSV)NL-OMON23402niversity Medical Center Utrecht348
已完成
2 期
Effect of mepolizumab in eosinophilic chronic rhinosinusitisChronic rhinosinusitisACTRN12618000113257Richard Harvey20